Table 3 Overview of policies in the phase of agenda-setting
| Â | Germany | Ireland | Netherlands | Poland |
|---|---|---|---|---|
National health surveillance or monitoring system | √ | √ | √ | √ |
Participation in EU health surveillance and monitoring systems | √ | √ | √ | √ |
Influence of prevalence data on policy development | √ | √ | √ | √ |
Influence of surveillance data on the national promotion of PA | √ | √ | - | - |